Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
about
Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient miceA variant associated with nicotine dependence, lung cancer and peripheral arterial diseaseDevelopment of administrative data algorithms to identify patients with critical limb ischemia.Endovascular therapy for critical limb ischemia.Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial diseasePlasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis.Disassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose toleranceNovel markers of peripheral arterial disease.The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia.Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.Percutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations.Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model.Review of the role of erythropoietin in critical leg ischemia.Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.Advanced glycation end-product (AGE)-albumin from activated macrophage is critical in human mesenchymal stem cells survival and post-ischemic reperfusion injury.Systemic inflammation following hind-limb ischemia-reperfusion affects brain in neonatal mice.APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.Lipid-lowering therapy is related to inflammatory markers and 3-year mortality in patients with critical limb ischemia.Inflammatory Cytokine Levels After Endovascular Therapy in Patients With Peripheral Artery Disease.Gender differences in outcome after stent treatment of lesions in the femoropopliteal segment.When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?
P2860
Q21144122-C57D5BD4-A576-49B0-8E28-D2C31D23627DQ29614871-C5C0E961-AEF9-4FB7-AD5C-CFC5E07E14B4Q30872920-40FEEDDD-098E-4288-824C-68DD5C6665E5Q33358621-6FA6DC44-8E82-451F-BDD6-A3205DD0865EQ33860219-F2722EFF-4023-429A-B150-9EBC6CB9FB53Q33863690-5373DF65-A8FC-4B8A-A979-C7BB8FB40622Q33968320-A60A2785-EDD3-448E-8821-B1A6D20D3A86Q33984026-A19643AB-DCC6-46B8-9DDC-C5DCA3488307Q34351686-F5990E6E-95F4-4C3A-88C0-A66D452AE12CQ35093012-252D1153-24B9-4D30-9E0B-302D22BFCEFDQ36146980-D93F5691-3A9C-479E-9482-78D830D2D86FQ36951957-213E9A61-FE63-4EE5-BDC3-C1FA102E3902Q37368874-4E39C64C-FB47-488E-8250-6E119FB9CEF7Q37409993-5ACF9312-1DCE-4265-8CE8-45AACBFDF8E5Q37750097-EE922AA0-BFA0-4D62-8A0C-95F64A2B59BEQ40114454-734E3B31-2E8F-4E33-AFFF-1A59B28D0CCEQ41051610-0E3703E0-861B-4081-AD64-ED302CB9643CQ43195385-15ABEAAA-D4AB-4298-BD10-5A3368C1E1A9Q43843460-22B52DBA-C27E-429E-8111-DF718F3272F8Q46664893-A419A66A-EFF8-49E4-A512-34AC69E719DEQ51278118-711E5822-3011-4006-A85A-BCEB0BEA3837Q51311692-CA0FD790-3EC6-4B07-B66A-97566E557959Q55127307-D15D355F-490A-4212-AEF9-F4D35855121D
P2860
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
@en
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
@nl
type
label
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
@en
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
@nl
prefLabel
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
@en
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
@nl
P2093
P1476
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia.
@en
P2093
Anders Gottsäter
Bengt Lindblad
Ingrid Mattiasson
Jamal Barani
Jan-Ake Nilsson
P356
10.1016/J.JVS.2005.03.025
P577
2005-07-01T00:00:00Z